Jacobio (01167) Announces Monthly Return for February 2026

Bulletin Express
03/02

Jacobio Pharmaceuticals Group Co., Ltd. (stock code: 01167) disclosed its monthly return report for the period ended 28 February 2026. The total authorized share capital remained at USD 100,000, representing 1.00 billion ordinary shares with a par value of USD 0.0001 each.

At the end of the month, the total number of issued shares (excluding treasury shares) stood at 786.67 million, with 5.08 million treasury shares held, resulting in 791.76 million shares issued in total. According to the filing, the company confirmed that it has satisfied the applicable public float requirement, specified at 25%. No changes were recorded in share options, warrants, convertibles, or other share issuance arrangements during this period.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10